FI963252A0 - Nya opioidpeptider för behandling av smärta samt deras användning - Google Patents

Nya opioidpeptider för behandling av smärta samt deras användning

Info

Publication number
FI963252A0
FI963252A0 FI963252A FI963252A FI963252A0 FI 963252 A0 FI963252 A0 FI 963252A0 FI 963252 A FI963252 A FI 963252A FI 963252 A FI963252 A FI 963252A FI 963252 A0 FI963252 A0 FI 963252A0
Authority
FI
Finland
Prior art keywords
peptides
pain
treatment
opioid
opioid peptides
Prior art date
Application number
FI963252A
Other languages
English (en)
Finnish (fi)
Other versions
FI963252A (sv
Inventor
William Brown
John Dimaio
Peter Schiller
Rene Martel
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9403263A external-priority patent/GB9403263D0/en
Priority claimed from SE9401519A external-priority patent/SE9401519D0/sv
Application filed by Astra Ab filed Critical Astra Ab
Publication of FI963252A0 publication Critical patent/FI963252A0/sv
Publication of FI963252A publication Critical patent/FI963252A/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI963252A 1994-02-21 1996-08-20 Nya opioidpeptider för behandling av smärta samt deras användning FI963252A (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9403263A GB9403263D0 (en) 1994-02-21 1994-02-21 Novel opiod peptides
GB9408179A GB9408179D0 (en) 1994-02-21 1994-04-25 Novel opioid peptides for the treatment of pain and use thereof
SE9401519A SE9401519D0 (sv) 1994-05-03 1994-05-03 Novel opioid peptides for the tratment of pain and use thereof
PCT/SE1995/000158 WO1995022557A1 (en) 1994-02-21 1995-02-15 Novel opioid peptides for the treatment of pain and use thereof

Publications (2)

Publication Number Publication Date
FI963252A0 true FI963252A0 (sv) 1996-08-20
FI963252A FI963252A (sv) 1996-08-20

Family

ID=27267061

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963252A FI963252A (sv) 1994-02-21 1996-08-20 Nya opioidpeptider för behandling av smärta samt deras användning

Country Status (20)

Country Link
EP (1) EP0746567B1 (sv)
JP (1) JPH09509168A (sv)
AT (1) ATE217011T1 (sv)
BR (1) BR9506847A (sv)
CA (1) CA2181367A1 (sv)
CZ (1) CZ288523B6 (sv)
DE (1) DE69526577T2 (sv)
EE (1) EE03265B1 (sv)
ES (1) ES2176322T3 (sv)
FI (1) FI963252A (sv)
HR (1) HRP950413A2 (sv)
HU (1) HUT74731A (sv)
IS (1) IS4261A (sv)
MX (1) MX9603489A (sv)
NO (1) NO963464L (sv)
NZ (1) NZ281742A (sv)
PL (1) PL181092B1 (sv)
SK (1) SK93596A3 (sv)
TW (1) TW408131B (sv)
WO (1) WO1995022557A1 (sv)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9503924D0 (sv) * 1995-08-18 1995-11-07 Astra Ab Novel opioid peptides
DK0853484T3 (da) * 1995-06-07 2003-01-20 Torrey Pines Inst Hidtil ukendte MU-opioid-receptorligander: agonister og antagonister
GB9516994D0 (en) * 1995-08-18 1995-10-18 Iaf Biochem Int Solution synthesis of peripheral acting analgestic opioid tetrapeptides
MX9709494A (es) * 1996-12-04 1998-07-31 Pfizer Compuestos peptidicos ciclicos, procedimiento para su produccion, composiciones que los contienen y uso de los mismos.
US5885958A (en) 1997-03-25 1999-03-23 Administrators Of The Tulane Educational Fund Mu-opiate receptor peptides
AU4572999A (en) 1998-06-18 2000-01-05 Sepracor, Inc. Tetrapeptides, analogs and peptidomimetics which bind selectively mammalian opioid receptors
SE9900961D0 (sv) * 1999-03-16 1999-03-16 Astra Ab Novel compounds
WO2001070684A2 (en) 2000-03-16 2001-09-27 Sepracor, Inc. Peptidomimetic ligands for cellular receptors and ion channels
US7498297B2 (en) 2000-07-18 2009-03-03 Cornell Research Foundation Medicinal uses of mu-opioid receptor agonists
EP3842055A1 (en) 2003-02-04 2021-06-30 Cornell Research Foundation, Inc. Uses of aromatic-cationic peptide
CN100506841C (zh) 2003-05-01 2009-07-01 科内尔研究基金会 将分子递送到细胞的方法和载体复合物
US7550439B2 (en) 2004-01-23 2009-06-23 Cornell Research Foundation, Inc. Methods for reducing oxidative damage
CN101166524B (zh) 2005-04-28 2010-12-22 辉瑞有限公司 氨基酸衍生物
EP3549594A1 (en) 2005-09-16 2019-10-09 Cornell Research Foundation, Inc. Aromatic-cationic peptide for use in a method for reducing cd36 expression
EP1782819A1 (en) 2005-11-03 2007-05-09 Cognis IP Management GmbH Oligopeptides and their use
US8906859B2 (en) 2006-11-10 2014-12-09 Cera Therapeutics, Inc. Uses of kappa opioid synthetic peptide amides
US7842662B2 (en) 2006-11-10 2010-11-30 Cara Therapeutics, Inc. Synthetic peptide amide dimers
US8236766B2 (en) 2006-11-10 2012-08-07 Cara Therapeutics, Inc. Uses of synthetic peptide amides
BRPI0718651B8 (pt) 2006-11-10 2021-05-25 Cara Therapeutics Inc amidas peptídicas sintéticas
US7713937B2 (en) 2006-11-10 2010-05-11 Cara Therapeutics, Inc. Synthetic peptide amides and dimeric forms thereof
CN102127152B (zh) * 2007-06-11 2012-07-04 北京大学 一种抗阿片肽的拮抗肽与该拮抗肽的应用
CN102127151B (zh) * 2007-06-11 2012-07-04 北京大学 抗阿片肽的拮抗肽与该拮抗肽的应用
CN101805396B (zh) * 2007-06-28 2011-09-14 北京大学 抗阿片肽的拮抗肽与该拮抗肽的应用
CN101817877B (zh) * 2007-06-28 2011-09-14 北京大学 一种抗阿片肽的活性片段
EP3272353A1 (en) 2008-02-07 2018-01-24 Cornell University Methods for preventing or treating insulin resistance
EP3741381B1 (en) 2008-02-26 2024-04-24 Cornell University A peptide for use for prevention and treatment of acute renal injury
JP2021525736A (ja) * 2018-05-31 2021-09-27 ザ・ユニバーシティ・オブ・シドニー 鎮痛剤及びその使用の方法
JP7437578B2 (ja) * 2019-03-20 2024-02-26 国立大学法人東北大学 新規オピオイドペプチド、その糖鎖付加体及びそれらを含む医薬組成物
CN113968902B (zh) * 2020-07-25 2023-05-26 兰州大学 亮氨酸-脑啡肽类似物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8005121A (nl) * 1979-09-20 1981-03-24 Erba Farmitalia Biologisch actieve peptiden.
DE69332826T2 (de) * 1992-11-12 2004-01-29 Sod Conseils Rech Applic Opioidpeptide
SE9300012D0 (sv) * 1993-01-05 1993-01-05 Astra Ab New peptides

Also Published As

Publication number Publication date
BR9506847A (pt) 1997-09-30
EE03265B1 (et) 2000-04-17
NZ281742A (en) 1997-06-24
AU690648B2 (en) 1998-04-30
CA2181367A1 (en) 1995-08-24
PL315947A1 (en) 1996-12-09
JPH09509168A (ja) 1997-09-16
TW408131B (en) 2000-10-11
AU1865195A (en) 1995-09-04
CZ288523B6 (cs) 2001-07-11
EP0746567A1 (en) 1996-12-11
HRP950413A2 (en) 1997-10-31
DE69526577T2 (de) 2003-01-02
MX9603489A (es) 1997-03-29
EP0746567B1 (en) 2002-05-02
SK93596A3 (en) 1997-05-07
HUT74731A (en) 1997-02-28
DE69526577D1 (de) 2002-06-06
WO1995022557A1 (en) 1995-08-24
FI963252A (sv) 1996-08-20
HU9602281D0 (en) 1996-10-28
IS4261A (is) 1995-08-22
NO963464L (no) 1996-08-20
CZ239196A3 (en) 1996-12-11
ATE217011T1 (de) 2002-05-15
PL181092B1 (pl) 2001-05-31
ES2176322T3 (es) 2002-12-01

Similar Documents

Publication Publication Date Title
FI963252A0 (sv) Nya opioidpeptider för behandling av smärta samt deras användning
SE9503924D0 (sv) Novel opioid peptides
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
ES2096312T3 (es) Derivado de quinuclidina como antagonista de la sustancia p.
DE60134453D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von ZNS und anderen Krankheiten
BR0108977A (pt) Compostos azacìclicos para uso no tratamento de doenças relaciondas com serotonina
KR930702022A (ko) 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
BRPI9708566A (pt) Análogo de glp-2, análogo de peptìdeo glp-humano, peptìdeo, composição farmacêutica, uso de um análogo de glp-2, e, processo para identificar análogos intestinotróficos de glp-2.
BR9709823B1 (pt) "compostos de amidas de ácido alqueno piridílico e alquino piridílico, métodos de preparação e uso dos mesmos, bem como medicamento".
FI925342A0 (sv) Förfarande för framställning av terapeutiskt aktiv (+)- -(2,3-dimetoxifenyl)-1-/2-(4-fluorfenyl)etyl/-4-piperidinmetanol
DE69627690D1 (de) Liposomale formulierungen von mitoxantron
IL97446A0 (en) Enhancement of the down-regulation of autoimmune diseases by oral administration of autoantigens
ZA952086B (en) Heterocyclic compounds their preparation and use
ES2174337T3 (es) Uso topico de los agonistas opioides kappa para el tratamiento del dolor ocular.
BG104179A (en) Phanquinon administration for the treatment of the alzheimer's disease
IL118833A (en) Sertraline for use as a medicament in the treatment of post-myocardial infarction patients
EP1164141A3 (en) Opioid peptides and their use for treatment of pain
TR199901385T2 (xx) Piperidin t�revleri.
SE9502877D0 (sv) Novel opioid peptides
YU24603A (sh) Novi farmaceutski preparati koji sadrže epinastin i pseudoefedrin
YU55095A (sh) Novi opioidni peptidi za lečenje bola i njihova primena novel
UA22223A (uk) Спосіб лікуваhhя захворюваhь оргаhа зору
RU97112616A (ru) Лекарственный препарат для лечения проктологических заболеваний
RU93049414A (ru) Производные бенз(е)индена